Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease.
about
Novel endoscopic techniques to image the upper gastrointestinal tractDifferential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectivesRate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies.Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn's disease.Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitisSerum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitisUtility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.The role and utility of faecal markers in inflammatory bowel disease.Quality of care in Crohn's disease.Therapeutic efficacy of pH-dependent release formulation of mesalazine on active ulcerative colitis resistant to time-dependent release formulation: analysis of fecal calprotectin concentrationPharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study.Mucosal healing in inflammatory bowel disease-a true paradigm of success?New pharmaceuticals in inflammatory bowel diseaseFecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis.Histologic markers of inflammation in patients with ulcerative colitis in clinical remission.Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study.Have genomic discoveries in inflammatory bowel disease translated into clinical progress?Mucosal healing with anti-TNF antibodies.Immunosuppressive and biologic therapy for ulcerative colitis.Recommendations for identifying Crohn's disease patients with poor prognosis.Deep remission in inflammatory bowel disease: looking beyond symptoms.Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum.First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?European evidence based consensus for endoscopy in inflammatory bowel disease.Ulcerative colitis or Crohn's disease? Pitfalls and problems.Novel concepts in inflammatory bowel disease.Endoscopic scoring systems for inflammatory bowel disease: pros and cons.Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease?Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease.Efficacy of exclusive enteral nutrition in complicated Crohn's disease.Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors.Clinical trials in ulcerative colitis: a historical perspective.Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease.Review article: the histological assessment of disease activity in ulcerative colitis.IOIBD technical review on endoscopic indices for Crohn's disease clinical trials.Compliance with the faecal calprotectin test in patients with inflammatory bowel disease.Mucosal Healing in Clinical Practice: A Single-Center Pediatric IBD Experience.Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
P2860
Q26784121-A612A65F-4D9A-4F1F-A938-B8A98331CA5CQ28085134-B002A5AD-AF1A-4331-A2A5-6021D94FA203Q33763285-289E3980-2342-4567-AB2D-3FD9B2918400Q33806908-347752FA-C0F8-408F-BB62-5D5D6AFBC96AQ33810986-F6B2F8C0-6DEE-4E6D-9A13-EC85EB40B3E3Q33840425-669B06B8-E405-45E7-B49A-E45937DC3A99Q34117832-33676E5C-78D6-4067-A0BC-E4FE3B9AF23FQ34456258-6FCD741F-5C77-49E9-A0C9-D4CC50C7384EQ34508859-D80C482F-352F-4E54-AAD5-457EB6517FEEQ34608415-D2E84A1B-CBB8-48B4-BB0A-8F4DE6F01FF2Q35044223-698D5AF0-FB2E-4345-831D-F19A8A242D4AQ35749943-DC3745A8-FCD7-4AE2-BD20-7E6E1D07F79AQ36243912-1129EEB3-09D0-4667-848F-3E2E8F409965Q36793729-211AADD5-2C72-4B56-A243-1C0F8998A9C0Q37122161-F09E4C77-C9E2-4D8F-9092-41143842F07EQ37231860-CC78E0C0-5196-4C69-BA14-C3CD162894B6Q37981121-AB792E33-AAFF-4B84-9C3D-422C717DEA47Q38050881-6FB4A50B-F5BC-4F5D-A878-3B7ED5F1B044Q38060831-FC5FF9C8-8AD9-4E85-8439-F0207ACB90AFQ38068962-EF469B22-5EF9-4E5E-BCBC-627663AD3593Q38077111-4CBDC003-3C31-4BF3-912E-7931EEC0D4C1Q38079831-00877AE5-7304-4DA8-90EC-1F4C1B09FE98Q38086355-865158D3-DFE8-4518-9211-670B21473474Q38144113-8BEEB7AF-6C04-4531-8627-9E464ED134AEQ38159096-5C4C6CF9-4EA3-4328-B4D4-22898C40E6DAQ38165241-D04252A6-D4AB-4DC1-BE35-A933CFC7A2EDQ38186010-784AD12C-B1AE-438B-9777-29560DD8EE7CQ38197726-BC194B6B-EC5C-4B6A-A22F-6F2AB887C8D1Q38217832-084A8702-E6D0-4358-B494-6AA6E13F5169Q38365049-4892DD5E-991E-4131-B142-28758C6AA8D5Q38375818-561E120F-5C7A-4CF4-AFAC-9F66C8D84921Q38394726-DCFD1045-DDC0-494D-BC1B-6D6BD0B559CDQ38396153-3D52CAD0-2B8A-4CBC-B338-C5BAB3E64383Q38443024-1D429317-E364-4B8C-978E-6CA1FA4217A7Q38542147-7F50BA0D-F143-4D7C-9E54-8F8E19FF79DEQ38573248-841D7DE2-07BB-4F39-9FE4-EC858C7D41D3Q38583688-07D08CBC-FD70-4B4F-B9D0-19A0A51A8523Q38641380-28C9C146-284D-494C-8C79-5DB3F50A331CQ38712270-2DD49AC8-DF0E-4520-AD3F-DF7CEF19F8FCQ38742261-D0B1E887-7061-4BB3-A1D9-E50221039848
P2860
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Results from the 2nd Scientifi ...... of inflammatory bowel disease.
@en
Results from the 2nd Scientifi ...... of inflammatory bowel disease.
@nl
type
label
Results from the 2nd Scientifi ...... of inflammatory bowel disease.
@en
Results from the 2nd Scientifi ...... of inflammatory bowel disease.
@nl
prefLabel
Results from the 2nd Scientifi ...... of inflammatory bowel disease.
@en
Results from the 2nd Scientifi ...... of inflammatory bowel disease.
@nl
P2093
P921
P1476
Results from the 2nd Scientifi ...... of inflammatory bowel disease.
@en
P2093
Andreas Sturm
Denis Franchimont
Gigi Veereman-Wauters
Hans Strid
Herma Fidder
Jean-Baptiste Chevaux
Marc Ferrante
Mathieu Allez
Sandro Ardizzone
Scientific Committee of the European Crohn's and Colitis Organization
P304
P356
10.1016/J.CROHNS.2011.06.009
P577
2011-08-03T00:00:00Z